When should a patient taking Tri-Cyclen Lo (norgestimate and ethinyl estradiol), a combination oral contraceptive, expect to have her menstrual period?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 19, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

When to Expect Menses on Tri-Cyclen Lo

Withdrawal bleeding (menstrual period) should occur during the 7-day hormone-free interval (placebo pill week) of each 28-day cycle, typically starting 2-3 days after beginning the inactive pills. 1

Standard Tri-Cyclen Lo Cycle Structure

Tri-Cyclen Lo follows a traditional cyclic combined oral contraceptive regimen with:

  • 21 days of active hormonal pills (containing norgestimate and ethinyl estradiol in a triphasic pattern: 180/215/250 mcg norgestimate with 25 mcg ethinyl estradiol) 2
  • 7 days of inactive placebo pills during which withdrawal bleeding occurs 1

Expected Bleeding Pattern

Most women will experience withdrawal bleeding during the hormone-free week, though the exact timing and characteristics vary:

  • Bleeding typically begins 2-3 days after starting the placebo pills 1
  • The bleeding pattern may be lighter and shorter than natural menstruation due to the lower estrogen dose (25 mcg) in Tri-Cyclen Lo 2
  • Unscheduled spotting or breakthrough bleeding is common during the first 3-6 months of use (14-17% of cycles in clinical trials), but this generally improves with continued use 1, 2

Important Clinical Considerations

Amenorrhea (Absence of Bleeding)

If withdrawal bleeding does not occur during the placebo week, pregnancy must be ruled out before continuing the next pack:

  • If one period is missed and pills were taken correctly, pregnancy is unlikely but should be considered 3
  • If two consecutive periods are missed, pregnancy must be ruled out regardless of adherence 3
  • Some women may experience amenorrhea while using combined oral contraceptives, which is not necessarily harmful but requires pregnancy exclusion 3

Breakthrough Bleeding Management

Unscheduled bleeding during active pill weeks is generally not harmful and does not indicate contraceptive failure:

  • Emphasize consistent daily pill-taking at the same time to minimize breakthrough bleeding 1
  • Bleeding irregularities typically resolve after 3-6 months of continuous use 1
  • If bleeding persists beyond 3-6 months or occurs after previously regular cycles, evaluate for pregnancy, missed pills, or underlying pathology 3

Extended/Continuous Regimens

While Tri-Cyclen Lo is packaged for traditional 28-day cycling, extended or continuous regimens (skipping placebo weeks) can be used to reduce or eliminate menstrual periods entirely:

  • This approach involves taking only active pills continuously for 84+ days or indefinitely 4, 5, 6
  • Extended regimens are particularly useful for managing menstrual-related symptoms like dysmenorrhea 7, 4
  • A planned 3-4 day hormone-free interval can be used to manage breakthrough bleeding if it occurs during extended use 1

Common Pitfalls to Avoid

  • Do not use withdrawal bleeding as a pregnancy test - absence of bleeding does not reliably exclude pregnancy, and presence of bleeding does not confirm non-pregnancy 3
  • Do not discontinue the pill due to early breakthrough bleeding - this is expected during the first 3-6 months and typically resolves with continued use 1
  • Do not assume amenorrhea indicates a problem - some women naturally experience very light or absent withdrawal bleeding on low-dose formulations like Tri-Cyclen Lo 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Evaluation of extended and continuous use oral contraceptives.

Therapeutics and clinical risk management, 2008

Guideline

Management of Severe Dysmenorrhea

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Related Questions

What are the continuous cycle birth control pills with 28 active pills per pack?
What is the recommended dosage and usage for Ortho Tri-Cyclen (norgestimate and ethinyl estradiol) for birth control?
Is it acceptable to start Ortho Tri-Cyclen Lo (norgestimate and ethinyl estradiol) immediately to stop a 3-month menstrual cycle in a 17-year-old?
How can birth control pills be used to prevent monthly menstrual periods?
How should I take my hormonal contraceptives (birth control pills) if my menstruation has already finished this month?
What are the signs and symptoms of rheumatic fever?
What is the cause of decreased sensation, pressure, and inner burning sensation in the anal region, as well as altered sensation during urination, in a patient with a history of anal fissure (fissurectomy with light lateral sphincterotomy) and hemorrhoidectomy, with no evidence of stenosis?
What is the best course of treatment for a middle-aged or older adult patient with a history of hypertension, well-controlled type 2 diabetes mellitus (T2DM), gastroesophageal reflux disease (GERD), and duodenal ulcer, presenting with right upper quadrant abdominal pain radiating to the epigastrium, marked transaminitis, elevated gamma-glutamyl transferase (GGT), and abdominal ultrasound findings of a distended gallbladder with echogenic sludge and tiny stones?
What does a urine drug screen result of 7608 ng/mL for benzoylecgonine (cocaine metabolite) indicate?
What are the risk factors for asthma, excluding comorbidities?
What is the initial treatment for a patient with cellulitis of the toe, considering potential underlying conditions such as diabetes?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.